Antibodies in Human Sera to Soluble and Viral Antigens Found in Burkitt Lymphoma and Other Lymphoblastoid Cell Lines2

Publisher Website
Google Scholar
Abstract
Human sera were examined for antibody to complement-fixing (CF) antigens derived from lymphobiastoid cell lines. Two CF antigens were used: a soluble cell extract (S) antigen, nonsedimentable at 100,000 × g for 2 hours, and a partially purified Epstein-Barr (EB) virus particle (V) antigen. The results of CF tests were compared with those of an indirect immunofluorescence (IF) test using fixed EB3 Burkitt lymphoma cells. Screening (at 1:10 dilution) of 177 sera indicated that, in 128 sera positive by the IF test, 106 reacted in the CF test with V antigen and 72 with the S antigen. Virtually all sera reactive with the S angiten also reacted with the V antigen. Forty-nine sera negative in the IF test were also negative when examined for CF-S and CF-V antibodies. Titration of positive sera by the 3 tests revealed a high correlation between the IF and CF-V antibody titer. On the other hand, many CF-S antibody-negative sera had high IF and CF-V antibody titers. The reactivity of human sera in the 3 tests suggests that the antigens detectable by the IF and CF-V tests are closely related, while the S antigen is immunologically distinct. In EB virus-containing cells, no correlation existed between the concentration of S antigen and virus particles or percent of IF-positive cells. The S antigen was also detected in preparations derived from AMC30 cells, free of detectable EB virions, but not in preparations of KB, HeLa, or human embryonic lung cells.

This publication has 0 references indexed in Scilit: